Citation: E. Von Stebut et Mc. Udey, Langerhans cells in cutaneous infections: Cellular bridges between innate and adaptive immunity, CURR P D-US, 13(3), 2001, pp. 167-172
Authors:
Belkaid, Y
Hoffmann, KF
Mendez, S
Kamhawi, S
Udey, MC
Wynn, TA
Sacks, DL
Citation: Y. Belkaid et al., The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptorantibody for sterile cure, J EXP MED, 194(10), 2001, pp. 1497-1506
Authors:
von Stebut, E
Belkaid, Y
Nguyen, BV
Cushing, M
Sacks, DL
Udey, MC
Citation: E. Von Stebut et al., Leishmania major-infected murine Langerhans cell-like dendritic cells fromsusceptible mice release IL-12 after infection and vaccinate against experimental cutaneous Leishmaniasis, EUR J IMMUN, 30(12), 2000, pp. 3498-3506
Authors:
Jakob, T
Walker, PS
Krieg, AM
von Stebut, E
Udey, MC
Vogel, JC
Citation: T. Jakob et al., Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: Implications for the augmentation of Th1 responses, INT A AL IM, 118(2-4), 1999, pp. 457-461
Authors:
Walker, PS
Scharton-Kersten, T
Krieg, AM
Love-Homan, L
Rowton, ED
Udey, MC
Vogel, JC
Citation: Ps. Walker et al., Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12-and IFN-gamma-dependent mechanisms, P NAS US, 96(12), 1999, pp. 6970-6975
Citation: T. Jakob et al., Characterization of E-cadherin-containing junctions involving skin-deriveddendritic cells, J INVES DER, 112(1), 1999, pp. 102-108